about
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vesselsAcetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcriptionFunctional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infectionRegulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoterRecruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML proteinEarly mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progressionMultiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharidesHuman synaptobrevin-like 1 gene basal transcription is regulated through the interaction of selenocysteine tRNA gene transcription activating factor-zinc finger 143 factors with evolutionary conserved cis-elementsInteraction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and sizeAdeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular systemVEGF gene therapy: therapeutic angiogenesis in the clinic and beyondNotch1 signaling stimulates proliferation of immature cardiomyocytesThe transcriptional co-activator PCAF regulates cdk2 activityInsights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein.Human origins of DNA replication selected from a library of nascent DNA.Microsurgical arterovenous loops and biological templates: a novel in vivo chamber for tissue engineering.The transcriptional transactivator Tat selectively regulates viral splicing.Interaction of the retinoblastoma protein with Orc1 and its recruitment to human origins of DNA replication.A candidate approach implicates the secreted Salmonella effector protein SpvB in P-body disassembly.Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage responseMulti-investigator letter on reproducibility of neonatal heart regeneration following apical resectionInhibition of choroidal and corneal pathologic neovascularization by Plgf1-de gene transfer.Characterization of a recombinant adeno-associated virus type 2 Reference Standard MaterialSubnuclear distribution of the largest subunit of the human origin recognition complex during the cell cycle.Nuclear architecture dictates HIV-1 integration site selection.Transgene detection by digital droplet PCRAdeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs.Functional screening identifies miRNAs inducing cardiac regeneration.Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material.Knockdown of cyclin-dependent kinase inhibitors induces cardiomyocyte re-entry in the cell cycleA new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14.Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemiaEffect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study.HIV Tat, its TARgets and the control of viral gene expression.Evaluation of nutritional status in head and neck radio-treated patients affected by oral mucositis: efficacy of class IV laser therapy.In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure.Proliferation of Multiple Cell Types in the Skeletal Muscle Tissue Elicited by Acute p21 Suppression.
P50
Q24299513-C65F3DF3-3405-400A-B0A7-A62655C6A058Q24310643-A995488C-FE5B-4775-8465-2E4340B9FC11Q24490032-BF2FB291-919F-4E10-BCEE-36239FFBE9ABQ24634457-F7CE8BD4-2FA7-46D8-8AF2-C0A32E2B8832Q24675942-1A86943C-A59D-4576-8DEA-C08BFD288FB4Q24681647-1EEF6EE2-1976-4E94-AF21-5EB95F8CF65BQ28144903-2DFDC412-98CA-44C1-9662-87AF1F1C63A2Q28191281-360554A9-B700-4861-A274-B7AD321C373FQ28235546-32A2313F-7ED3-4A29-B458-D6548DDECF86Q28240642-D2DA6521-FECA-4E04-A48D-6341A4E4BD00Q28260984-76204988-FF65-4723-99DC-A523AFA5B30AQ28565088-0338A481-ACFA-4314-A7B3-AA5A74D622BFQ28592663-45B05640-ADD6-42E1-9BB3-DA3F4DA2D809Q31026877-CB24FC01-0B2E-417A-8A2A-8A4D23127E22Q31135334-9568E8AB-847D-415D-99EA-9F91F15B2167Q33221947-974F61B4-E37C-42EE-B8E1-746AF86C8C2EQ33298996-52A3FC6E-5FEA-4C02-92D3-91D47A5E1A94Q33700143-5BA7C950-134B-446D-A3A2-423DB78EC42BQ33749849-915D3371-1E8E-4CEE-B689-BAE6B8B8C046Q33842068-5B70E7C7-9A98-427E-9F9F-87C059287455Q33870310-7DEB4F19-B0C9-4CAB-B405-508D7D7FBEE7Q33881246-9D873A69-47E8-4BFB-A822-2A19D17C1634Q33924341-2709CC54-C30D-491C-9AAD-626CE0484785Q33949120-571C9F14-A890-4247-A8C3-2D2B7DBA5FD3Q33961137-0A8C5603-941B-4A7F-93D0-9EF773352621Q34211507-D4CBE517-F021-4D53-9D06-FD118608BDE2Q34354028-924B7AA5-66E9-43F9-A5E9-113EDB453E94Q34465264-F0B92E0B-DD90-438B-8B13-523F4E2E8046Q34465859-49AB9E67-786B-456E-A7CC-F0CDD3E1EDFEQ34502913-83BF5CF0-F4FF-4BDC-8D4A-B18344A9A2C7Q34504097-03C16A16-FB4C-4E64-8CA5-9C60642BF226Q34535446-08CFC30D-3B60-4852-9738-3908E0B47863Q34624538-16FF93EE-1B24-4AFD-9B65-1CBEEDFC95FDQ34734933-1683F6A0-18A1-49FD-9E22-BEC89DF920ECQ34788546-DFA2D041-D69B-4AC1-B75A-F96ECC53C40FQ35008427-CA2C9F96-BFA5-4451-9494-2189C9D0897EQ35088029-97BF572C-20C6-441A-8934-05BD3DACB770Q35098450-232D9781-6A72-4AC5-B8F7-B9ED8A891E6EQ35222600-B210839B-58A4-4E65-9A0D-D90D4CF01F94Q35582038-0C57E9A2-6E1A-4D3B-A817-72D7CC383463
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mauro Giacca
@ast
Mauro Giacca
@en
Mauro Giacca
@es
Mauro Giacca
@nl
type
label
Mauro Giacca
@ast
Mauro Giacca
@en
Mauro Giacca
@es
Mauro Giacca
@nl
prefLabel
Mauro Giacca
@ast
Mauro Giacca
@en
Mauro Giacca
@es
Mauro Giacca
@nl
P214
P106
P1153
7005255834
P214
P31
P496
0000-0003-2927-7225
P7859
lccn-no2010121529